McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan is quoted in a November 5, 2014 edition of The Wall Street Journal Pharmalot Blog in an article entitled, “Sue Me, Sue You Blues: More Generic Patent Litigation is Being Filed.” Over the past decade, generic drug makers have benefited tremendously from the so-called patent cliff, which is shorthand for the spate of big-selling, brand-name medicines that began to lose patent protection. This translated into one golden opportunity after another for the generic pharmaceutical industry, which continues to ring registers with lower-cost, copycat versions. View the article
